Waters Parkerson & Co’s Bristol-Myers Squibb BMY Stock Holding History

Waters Parkerson & Co’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$694K	Sell	12,037 -575	-5%	-$33K	0.03%	123
2026 Q1	$765K	Hold	12,612	–	–	0.04%	111
2025 Q4	$680K	Sell	12,612 -5,018	-28%	-$241K	0.03%	122
2025 Q3	$795K	Buy	17,630 +5,625	+47%	+$263K	0.04%	111
2025 Q2	$556K	Hold	12,005	–	–	0.03%	127
2025 Q1	$732K	Hold	12,005	–	–	0.04%	117
2024 Q4	$679K	Hold	12,005	–	–	0.04%	118
2024 Q3	$621K	Sell	12,005 -500	-4%	-$23.5K	0.03%	122
2024 Q2	$519K	Sell	12,505 -80	-0.6%	-$3.58K	0.03%	121
2024 Q1	$682K	Sell	12,585 -8,400	-40%	-$428K	0.04%	112
2023 Q4	$1.08M	Buy	20,985 +2,039	+11%	+$107K	0.06%	91
2023 Q3	$1.1M	Sell	18,946 -300	-2%	-$18.4K	0.07%	92
2023 Q2	$1.23M	Sell	19,246 -1,035	-5%	-$69.4K	0.07%	87
2023 Q1	$1.41M	Sell	20,281 -85	-0.4%	-$6K	0.08%	81
2022 Q4	$1.47M	Hold	20,366	–	–	0.09%	79
2022 Q3	$1.45M	Hold	20,366	–	–	0.1%	77
2022 Q2	$1.57M	Hold	20,366	–	–	0.1%	75
2022 Q1	$1.49M	Hold	20,366	–	–	0.08%	83
2021 Q4	$1.27M	Sell	20,366 -14,315	-41%	-$840K	0.07%	88
2021 Q3	$2.05M	Hold	34,681	–	–	0.12%	72
2021 Q2	$2.32M	Sell	34,681 -332	-0.9%	-$21.6K	0.13%	68
2021 Q1	$2.21M	Sell	35,013 -900	-3%	-$56K	0.14%	68
2020 Q4	$2.23M	Buy	35,913 +600	+2%	+$36.9K	0.15%	65
2020 Q3	$2.13M	Sell	35,313 -1,413	-4%	-$85K	0.16%	63
2020 Q2	$2.16M	Sell	36,726 -150	-0.4%	-$8.97K	0.18%	62
2020 Q1	$2.06M	Buy	36,876 +1,392	+4%	+$85.1K	0.2%	62
2019 Q4	$2.28M	Sell	35,484 -517	-1%	-$29.6K	0.17%	66
2019 Q3	$1.83M	Sell	36,001 -994	-3%	-$46.7K	0.15%	67
2019 Q2	$1.68M	Buy	36,995 +1,750	+5%	+$81.5K	0.14%	69
2019 Q1	$1.68M	Sell	35,245 -2,964	-8%	-$148K	0.14%	69
2018 Q4	$1.99M	Sell	38,209 -632	-2%	-$34K	0.19%	64
2018 Q3	$2.41M	Sell	38,841 -334	-0.9%	-$19.8K	0.2%	63
2018 Q2	$2.17M	Sell	39,175 -902	-2%	-$48.7K	0.19%	64
2018 Q1	$2.54M	Sell	40,077 -1,195	-3%	-$76.9K	0.22%	61
2017 Q4	$2.53M	Hold	41,272	–	–	0.21%	61
2017 Q3	$2.63M	Buy	41,272 +500	+1%	+$29.2K	0.23%	60
2017 Q2	$2.27M	Sell	40,772 -50	-0.1%	-$2.72K	0.21%	65
2017 Q1	$2.22M	Sell	40,822 -63	-0.2%	-$3.46K	0.21%	65
2016 Q4	$2.39M	Buy	40,885 +9,570	+31%	+$523K	0.24%	60
2016 Q3	$1.69M	Buy	31,315 +980	+3%	+$63K	0.17%	69
2016 Q2	$2.23M	Sell	30,335 -590	-2%	-$41.7K	0.24%	63
2016 Q1	$1.98M	Buy	30,925 +970	+3%	+$61.2K	0.22%	64
2015 Q4	$2.06M	Sell	29,955 -25	-0.1%	-$1.65K	0.24%	63
2015 Q3	$1.77M	Sell	29,980 -250	-0.8%	-$15.9K	0.23%	64
2015 Q2	$2.01M	Buy	30,230 +467	+2%	+$30.8K	0.24%	64
2015 Q1	$1.92M	Sell	29,763 -300	-1%	-$18.8K	0.22%	66
2014 Q4	$1.77M	Sell	30,063 -589	-2%	-$33.2K	0.21%	67
2014 Q3	$1.57M	Sell	30,652 -3,371	-10%	-$168K	0.19%	69
2014 Q2	$1.65M	Sell	34,023 -100	-0.3%	-$4.93K	0.2%	67
2014 Q1	$1.77M	Buy	34,123 +70	+0.2%	+$3.73K	0.22%	64
2013 Q4	$1.81M	Buy	34,053 +2,653	+8%	+$135K	0.22%	63
2013 Q3	$1.45M	Buy	31,400 +14,115	+82%	+$620K	0.2%	68
2013 Q2	$772K	Buy	+17,285	New	+$750K	0.11%	75

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Waters Parkerson & Co's BMY Position: Q2 2026 in Review

Waters Parkerson & Co reduced its Bristol-Myers Squibb (BMY) stake by 4.6% in Q2 2026, selling an estimated $33K and leaving 12,037 shares worth $694K. The position accounts for 0.03% of the portfolio, ranked #123.

Waters Parkerson & Co first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.63M in Q3 2017. 1,611 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Waters Parkerson & Co held 12,037 shares of Bristol-Myers Squibb worth $694K as of Q2 2026.
Waters Parkerson & Co sold 575 Bristol-Myers Squibb shares in Q2 2026, an estimated $33K.
Bristol-Myers Squibb made up 0.03% of Waters Parkerson & Co's portfolio in Q2 2026, its #123 holding.
Waters Parkerson & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
Waters Parkerson & Co's Bristol-Myers Squibb position peaked at $2.63M in Q3 2017.
1,611 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Waters Parkerson & Co's 13F filing for Q2 2026, filed 30 Jul 2026.